Nature Biotechnology Conferences
Pullman Beijing South 12 Rong Hua Nan Lu, Beijing, ChinaNature Medicine, Nature Microbiology and Nature Biotechnology present:
Countering Antimicrobial Resistance
CARB-X welcomes on-line applications for funding of antibacterial projects
CARB-X 765 Commonwealth Ave, Boston, MA, United StatesInformation on the scope of funding and how to apply - closes 5:00 EDT on June 8, 2018.
BIO International Convention 2018
Boston Convention Center 415 Summer St, Boston, MA, United StatesBIO 2018 Life Sciences Convention
ASM Microbe 2018 – Presentation by Karen Gallant
Georgia World Congress Center 285 Andrew Young International Blvd NW, Atlanta, GA, United StatesKaren Gallant to present at the American Society of Microbiology - connecting scientists with their science
Webinar: Antibacterial Drugs: Clinical Development for Non-Developers Part 1 ‘Traditional development – tiers A and B
WebinarLearn more about clinical development of antibiotics! Webinar with David Schlaes
Understanding the Development Challenges Associated with Emerging Non-Traditional Antibiotics
JW Marriott Washington DC 1331 Pennsylvania Avenue NW, Washington, DC, United StatesConvened by the Duke-Robert J. Margolis, MD, Center for Health Policy at Duke University and supported by a cooperative agreement with FDA, this public event will focus on the range of non-traditional pharmaceutical approaches being developed to combat bacterial infections. Kevin Outterson and John Rex to present.
GARDP Live Discussion Webinar: PK-PD in support of accelerated programmes for antimicrobial development: how much is enough?
WebinarIn this webinar, William Hope will talk about the role of pharmacokinetics and pharmacodynamics for antimicrobial drug development. He will discuss the EMA guideline on the use of PK/PD and basic studies to inform dose finding strategies. He will also advise on realistic benchmarking, endpoints, and interpretation of study results.
Payment Reform Pathways for Antimicrobial Drugs: Duke-Margolis Center for Health Policy Roundtable Meeting
Washington, DCFacilitating Payment Reform Pathways for Antimicrobial Drugs through FDA and CMS Collaboration As you know, the rise in antimicrobial resistant infections is a major public health threat. Few treatment options are available and the pipeline of drug candidates is extremely limited. To help address this issue, Duke-Margolis has been focused on policy initiatives that could […]
FDA Development of Non-Traditional Therapies for Bacterial Infections Workshop
FDA White Oak Campus - Building 31 10903 New Hampshire Ave, Silver Spring, MD, United StatesThe Food and Drug Administration is holding a public workshop entitled “Development of Non-Traditional Therapies for Bacterial Infections." The purpose of the public workshop is to discuss the general development considerations of non-traditional therapies, including pre-clinical development, early clinical studies, and phase 3 clinical trial designs to evaluate safety and efficacy. Presentations by Kevin Outterson, […]
Next Generation Dx Summit: Investment Plenary Panel – Changing Approaches to Sustainable Funding in Diagnostics
Grand Hyatt Washington 1000 H St NW, Washington, DC, United StatesToday, many innovators in the diagnostics industry struggle for funding, and yet news of large scale acquisitions or large (over $30M) funding rounds pops up regularly. How can innovators better understand the changing dynamics of the funding environment to succeed? How can investors know if they are getting exposed to the potentially best investments? Whether […]